Recombinant human activated protein C attenuates cardiovascular and microcirculatory dysfunction in acute lung injury and septic shock

被引:13
|
作者
Maybauer, Marc O. [1 ,2 ,3 ,4 ,5 ]
Maybauer, Dirk M. [1 ,2 ,3 ]
Fraser, John F. [4 ,5 ]
Szabo, Csaba [1 ,2 ]
Westphal, Martin [1 ,2 ]
Kiss, Levente [6 ]
Horvath, Eszter M. [6 ]
Nakano, Yoshimitsu [1 ,2 ]
Herndon, David N. [7 ,8 ]
Traber, Lillian D. [1 ,2 ]
Traber, Daniel L. [1 ,2 ]
机构
[1] Univ Texas Med Branch, Dept Anesthesiol, Invest Intens Care Unit, Galveston, TX 77555 USA
[2] Shriners Burns Hosp Children, Galveston, TX 77555 USA
[3] Univ Marburg, Dept Anaesthesiol & Intens Care, D-35033 Marburg, Germany
[4] Prince Charles Hosp Brisbane, Chermside, Qld 4032, Australia
[5] Univ Queensland, Crit Care Res Grp, Chermside, Qld 4032, Australia
[6] Semmelweis Univ, Inst Human Physiol & Clin Expt, H-1094 Budapest, Hungary
[7] Univ Texas Med Branch, Dept Surg, Galveston, TX 77550 USA
[8] Shriners Burns Hosp Children, Galveston, TX 77550 USA
基金
美国国家卫生研究院;
关键词
SMOKE-INHALATION INJURY; MICROVASCULAR BLOOD-FLOW; SEVERE SEPSIS; PEROXYNITRITE; HYPOTENSION; IMPROVES; MODEL; HEMODYNAMICS; VENTILATION; INHIBITION;
D O I
10.1186/cc9342
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: This prospective, randomized, controlled, experimental animal study looks at the effects of recombinant human activated protein C (rhAPC) on global hemodynamics and microcirculation in ovine acute lung injury (ALI) and septic shock, resulting from smoke inhalation injury. Methods: Twenty-one sheep (37 +/- 2 kg) were operatively prepared for chronic study and randomly allocated to either the sham, control, or rhAPC group (n = 7 each). The control and rhAPC groups were subjected to insufflation of four sets of 12 breaths of cotton smoke followed by instillation of live Pseudomonas aeruginosa into both lung lobes, according to an established protocol. Healthy sham animals were not subjected to the injury and received only four sets of 12 breaths of room air and instillation of the vehicle (normal saline). rhAPC (24 mu g/kg/hour) was intravenously administered from 1 hour post injury until the end of the 24-hour experiment. Regional microvascular blood flow was analyzed using colored microspheres. All sheep were mechanically ventilated with 100% oxygen, and fluid resuscitated with lactated Ringer's solution to maintain hematocrit at baseline levels. Results: The rhAPC-associated reduction in heart malondialdehyde (MDA) and heart 3-nitrotyrosine (a reliable indicator of tissue injury) levels occurred parallel to a significant increase in mean arterial pressure and to a significant reduction in heart rate and cardiac output compared with untreated controls that showed a typical hypotensive, hyperdynamic response to the injury (P < 0.05). In addition, rhAPC significantly attenuated the changes in microvascular blood flow to the trachea, kidney, and spleen compared with untreated controls (P < 0.05 each). Blood flow to the ileum and pancreas, however, remained similar between groups. The cerebral blood flow as measured in cerebral cortex, cerebellum, thalamus, pons, and hypothalamus, was significantly increased in untreated controls, due to a loss of cerebral autoregulation in septic shock. rhAPC stabilized cerebral blood flow at baseline levels, as in the sham group. Conclusions: We conclude that rhAPC stabilized cardiovascular functions and attenuated the changes in visceral and cerebral microcirculation in sheep suffering from ALI and septic shock by reduction of cardiac MDA and 3-nitrotyrosine.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Recombinant human activated protein C
    Hughes, Martin
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 28 (02) : 90 - 94
  • [42] Effects of recombinant activated protein C and heparin on neutrophil-endothelial cell interactions in septic shock
    Correa-Lopez, W
    Kirschenbaum, LA
    Astiz, ME
    CRITICAL CARE MEDICINE, 2005, 33 (12) : A135 - A135
  • [43] Design and conduct of the activated protein C and corticosteroids for human septic shock (APROCCHSS) trial
    Annane, Djillali
    Buisson, Christian Brun
    Cariou, Alain
    Martin, Claude
    Misset, Benoit
    Renault, Alain
    Lehmann, Blandine
    Millul, Valerie
    Maxime, Virginie
    Bellissant, Eric
    ANNALS OF INTENSIVE CARE, 2016, 6
  • [44] Design and conduct of the activated protein C and corticosteroids for human septic shock (APROCCHSS) trial
    Djillali Annane
    Christian Brun Buisson
    Alain Cariou
    Claude Martin
    Benoit Misset
    Alain Renault
    Blandine Lehmann
    Valérie Millul
    Virginie Maxime
    Eric Bellissant
    Annals of Intensive Care, 6
  • [45] Inhaled activated protein C: a novel therapy for acute lung injury?
    Liu, Kathleen D.
    Looney, Mark R.
    Matthay, Michael A.
    CRITICAL CARE, 2009, 13 (03)
  • [46] Inhaled activated protein C: a novel therapy for acute lung injury?
    Kathleen D Liu
    Mark R Looney
    Michael A Matthay
    Critical Care, 13
  • [47] Activated protein c reduces acute lung injury in endotoxemic sheep
    Kuklin, VN
    INTENSIVE CARE MEDICINE, 2003, 29 : S190 - S190
  • [48] Recombinant human activated protein C ameliorates oleic acid-induced lung injury in awake sheep
    Waerhaug, Kristine
    Kirov, Mikhail Y.
    Kuzkov, Vsevolod V.
    Kuklin, Vladimir N.
    Bjertnaes, Lars J.
    CRITICAL CARE, 2008, 12 (06):
  • [49] Activated protein C attenuates leukocyte elastase-induced lung injury in mice
    Tanaka, Akihiko
    Minoguchi, Kenji
    Chen, Xiaoyang
    Oda, Naruhito
    Yokoe, Takuya
    Yamamoto, Yoshitaka
    Yamamoto, Mayumi
    Watanabe, Yoshio
    Ohta, Shin
    Xu, Xun
    Adachi, Mitsuru
    SHOCK, 2008, 30 (02): : 153 - 158
  • [50] Inhaled activated protein C attenuates lung injury induced by aerosolized endotoxin in mice
    Kotanidou, Anastasia
    Loutrari, Heleni
    Papadomichelakis, Evangelos
    Glynos, Constantinos
    Magkou, Christina
    Armaganidis, Apostolos
    Papapetropoulos, Andreas
    Roussos, Charis
    Orfanos, Stylianos E.
    VASCULAR PHARMACOLOGY, 2006, 45 (02) : 134 - 140